Gallen International Breast Cancer Conference revised the criterion on the identification of luminal A and luminal B (HER2-negative) subtypes [4], based on ER, PR and Ki-67 status [5, 6]; the use of histological grade for this purpose was previously declined [7]. This evidence concerns the gene ERBB2 and breast cancer.